7investing (@7investing) 's Twitter Profile
7investing

@7investing

Empowering you to invest in your future! Offering our 7 top stock market opportunities every month @ 7investing.com/subscribe.

ID: 1141416525972291584

linkhttps://7investing.com/subscribe calendar_today19-06-2019 18:44:41

4,4K Tweet

23,23K Followers

176 Following

Simon Erickson (@7innovator) 's Twitter Profile Photo

I read through the first 25 pages of the Scorpion short report on TransMedics $TMDX (it was getting repetitive and I didn't have the patience to read through all 342). It's very clear that they are relying on incendiary language and anecdotal quotes from anonymous 'expert'

Simon Erickson (@7innovator) 's Twitter Profile Photo

🙏🙏🙏 "This is about as great of a write up as I’ve ever seen. Simon is the best. We are all fortunate to be part of the 7investing team. He’s a passionate guy who wants to see everyone do great. Was so happy I found this company."

🙏🙏🙏

"This is about as great of a write up as I’ve ever seen. Simon is the best. We are all fortunate to be part of the <a href="/7investing/">7investing</a> team.

He’s a passionate guy who wants to see everyone do great. Was so happy I found this company."
Simon Erickson (@7innovator) 's Twitter Profile Photo

I hope you've been enjoying our 7investing Company Updates! We've gotten off to a great start in 2025 and have now published a company-specific update on every business day of the new year. Here are the companies we have on tap for next week: - BeiGene / BeOne Medicines $BGNE

I hope you've been enjoying our <a href="/7investing/">7investing</a> Company Updates! 

We've gotten off to a great start in 2025 and have now published a company-specific update on every business day of the new year.

Here are the companies we have on tap for next week:
- BeiGene / BeOne Medicines $BGNE
Simon Erickson (@7innovator) 's Twitter Profile Photo

RocketMan $RKLB 7investing The 1,4,8,8 is what I believe is the most-likely launch cadence for Neutron. The commercial customer they signed for 2026 is under contract; not a test with zero revenue. But I still think they're going to get Neutron to the pad by the end of this year.

<a href="/RKLBMan/">RocketMan $RKLB</a> <a href="/7investing/">7investing</a> The 1,4,8,8 is what I believe is the most-likely launch cadence for Neutron.

The commercial customer they signed for 2026 is under contract; not a test with zero revenue. But I still think they're going to get Neutron to the pad by the end of this year.
Simon Erickson (@7innovator) 's Twitter Profile Photo

I'm excited to reveal 7investing's twelve highest-conviction stocks that we recommend investors buy in January 2025. We've now done diligence on more than 200 companies and have nearly 120 active recommendations. We identify the top 10% of those as "Strong Buys", which

I'm excited to reveal <a href="/7investing/">7investing</a>'s twelve highest-conviction stocks that we recommend investors buy in January 2025.

We've now done diligence on more than 200 companies and have nearly 120 active recommendations. We identify the top 10% of those as "Strong Buys", which
Simon Erickson (@7innovator) 's Twitter Profile Photo

🚨My 5 Best Buys for January 2025.🚨 Background: Stocks as a whole aren't particularly cheap right now. But there's incredible opportunities lurking in the right places. 2024's election of Donald Trump was immediately met with stock market optimism. The S&P 500's $SPY

🚨My 5 Best Buys for January 2025.🚨

Background: 
Stocks as a whole aren't particularly cheap right now. But there's incredible opportunities lurking in the right places.

2024's election of Donald Trump was immediately met with stock market optimism. The S&amp;P 500's $SPY
Simon Erickson (@7innovator) 's Twitter Profile Photo

Tandem Diabetes Care's $TNDM mission is to simplify the lives of people living with diabetes. Its automated pump delivers insulin to patients continually throughout the day, rather than just self-injections after meals. But Tandem's top-line growth is failing to generate

Tandem Diabetes Care's $TNDM mission is to simplify the lives of people living with diabetes. 

Its automated pump delivers insulin to patients continually throughout the day, rather than just self-injections after meals.

But Tandem's top-line growth is failing to generate
Simon Erickson (@7innovator) 's Twitter Profile Photo

Crocs is a very inexpensive stock right now, which could represent an excellent value investment opportunity. $CROX is a global shoe retailer whose comfortable and inexpensive footwear generates $4 billion in annual sales. Its core Crocs brand is growing 17% internationally and

Crocs is a very inexpensive stock right now, which could represent an excellent value investment opportunity.

$CROX is a global shoe retailer whose comfortable and inexpensive footwear generates $4 billion in annual sales.

Its core Crocs brand is growing 17% internationally and
Simon Erickson (@7innovator) 's Twitter Profile Photo

As of today, the 62 stocks I've officially recommended for 7investing have collectively: - Generated an average absolute return of 50.3% since the day they were recommended - Outperformed the S&P 500's absolute return of 40.5% during the same timeframe by 980 basis points -

As of today, the 62 stocks I've officially recommended for <a href="/7investing/">7investing</a> have collectively:

- Generated an average absolute return of 50.3% since the day they were recommended
- Outperformed the S&amp;P 500's absolute return of 40.5% during the same timeframe by 980 basis points
-
Simon Erickson (@7innovator) 's Twitter Profile Photo

Guardant Health just received an important new reimbursement coverage and has aggressively been increasing its full-year sales forecast. This week, Guardant Health $GH received full reimbursement coverage from Medicare provider Palmetto GBA for its REVEAL test. REVEAL is a

Guardant Health just received an important new reimbursement coverage and has aggressively been increasing its full-year sales forecast.

This week, Guardant Health $GH received full reimbursement coverage from Medicare provider Palmetto GBA for its REVEAL test. REVEAL is a
Simon Erickson (@7innovator) 's Twitter Profile Photo

I'm very excited to present at MoneyShow's 2025 Masters Symposium! I'll be presenting this year on disruptive innovation and will be featuring my favorite investment opportunities in quantum computing, AI, and the space economy. Let me know if you'll be in the Dallas area on

I'm very excited to present at <a href="/MoneyShow/">MoneyShow</a>'s 2025 Masters Symposium!

I'll be presenting this year on disruptive innovation and will be featuring my favorite investment opportunities in quantum computing, AI, and the space economy.

Let me know if you'll be in the Dallas area on
Simon Erickson (@7innovator) 's Twitter Profile Photo

I think if we're being honest with ourselves, we're all in a state of shock over DeepSeek's recent announcement. DeepSeek's R1 model requires significantly less computing to train its AI. That means fewer processors and less money spent on infrastructure. Bad news for NVIDIA.

I think if we're being honest with ourselves, we're all in a state of shock over DeepSeek's recent announcement.

DeepSeek's R1 model requires significantly less computing to train its AI. That means fewer processors and less money spent on infrastructure.

Bad news for NVIDIA.
7investing (@7investing) 's Twitter Profile Photo

$ASML just got a 4Q subscriber page boost! For access to this update and our research on more than 200 companies: 7investing.com/subscribe

Simon Erickson (@7innovator) 's Twitter Profile Photo

Starbucks $SBUX just reported its Q1 2025 results and yikes! An (8%) drop in traffic in its core North American segment drove a (4%) overall decline in global same-store sales. Incoming CEO Brian Niccol recently announced a "Back to Starbucks" strategic action plan that's

Starbucks $SBUX just reported its Q1 2025 results and yikes! 

An (8%) drop in traffic in its core North American segment drove a (4%) overall decline in global same-store sales.

Incoming CEO Brian Niccol recently announced a "Back to Starbucks" strategic action plan that's
Simon Erickson (@7innovator) 's Twitter Profile Photo

Last year Ferrari $RACE unveiled its newest F80 racecar, which incorporates features from Endurance motor competitions and Formula 1. It has 1184 horsepower, a top speed of 220 mph, and can go 0-60 in 2.2 seconds. And with a price tag of $3.8 million, it is the carmaker's most

Last year Ferrari $RACE unveiled its newest F80 racecar, which incorporates features from Endurance motor competitions and Formula 1.

It has 1184 horsepower, a top speed of 220 mph, and can go 0-60 in 2.2 seconds.

And with a price tag of $3.8 million, it is the carmaker's most
Simon Erickson (@7innovator) 's Twitter Profile Photo

What is your favorite small-cap growth stock to invest in right now? I will publish all results in a 7investing article tomorrow morning. And I'll give full attribution + a link to your Twitter profile to everyone who shares an idea.

Simon Erickson (@7innovator) 's Twitter Profile Photo

Dominos’ Cash Flow Dilemma: Are There Enough Slices to Feed Everyone? Domino's $DPZ, the world's largest and arguably most-delicious pizza chain, reported in its FY 2024 results that same-store-sales grew 3.2% domestically and 1.6% internationally. After factoring in the 775

Dominos’ Cash Flow Dilemma: Are There Enough Slices to Feed Everyone?

Domino's $DPZ, the world's largest and arguably most-delicious pizza chain, reported in its FY 2024 results that same-store-sales grew 3.2% domestically and 1.6% internationally.

After factoring in the 775
Simon Erickson (@7innovator) 's Twitter Profile Photo

Which stock would you like me to cover in our next 7investing podcast on Tuesday, May 13? $AMD $LMND $RKLB $TTD open.spotify.com/show/7wBWhst8U…

Simon Erickson (@7innovator) 's Twitter Profile Photo

Our 7investing Best Buys for April just knocked it out of the park. Our top pick -- which remained at the helm for the second straight month -- just soared 63% during the past 30 days. I loved seeing our investors make a ton of money. That one was an innovative and very

Our <a href="/7investing/">7investing</a> Best Buys for April just knocked it out of the park.

Our top pick -- which remained at the helm for the second straight month -- just soared 63% during the past 30 days.

I loved seeing our investors make a ton of money. That one was an innovative and very